Literature DB >> 25018137

Changes of body composition in patients with BMI 23-50 after tailored one anastomosis gastric bypass (BAGUA): influence of diabetes and metabolic syndrome.

M Garciacaballero1, A Reyes-Ortiz, M García, J M Martínez-Moreno, J A Toval, A García, A Mínguez, D Osorio, J M Mata, F Miralles.   

Abstract

BACKGROUND: The use of bariatric surgery to treat diabetes mellitus (DM) requires procedures developed for morbid obese in patients with normal and over-weight. Therefore, we started tailoring one anastomosis gastric bypass (BAGUA) adapted to each patient. This study analyzes changes in body composition (BC) of patients with BMI 23-50 after BAGUA as well as influence of DM and MS.
METHODS: We studied 79 (37 diabetic and 42 non-diabetic) patients (BMI 23-50) who completed all evaluation appointment (preoperative, 10 days, 1, 3, 6, and 12 months) after tailored BAGUA for obesity, diabetes, or diabesity. Patients were classified according to BMI (23-29, 30-34, 35-50) and bearing or not diabetes. Variables are components of BC as well as DM and MS.
RESULTS: Preoperatively, mean values of weight varied 37 kg (78-115 kg), muscle mass (MM) 8 kg (54-62 kg), while fat mass (FM) 30 kg (22-53 kg). Basal metabolism (BM) was higher in diabetic. After surgery, percentage (%) of excess weight loss (%EWL) ranged from 76 % (BMI 35-50) to 128 % (BMI 23-29), FM 56 % (BMI 23-29) to 65 % (BMI 35-50), without differences bearing DM. MM 12 % (non-diabetics BMI 30-34) to 17 % (diabetics BMI 35-50) and visceral fat (VF) 50 % (diabetics BMI 30-34) to 56 % (non-diabetics BMI 35-50).
CONCLUSIONS: After tailored BAGUA, MM maintains steady while FM is highly reduced and variable. BM is reduced in all groups. Diabetics lose less weight and VF but more MM than non-diabetic patients. Preoperative presence of MS influences the changes in BC.

Entities:  

Mesh:

Year:  2014        PMID: 25018137     DOI: 10.1007/s11695-014-1288-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  28 in total

1.  Energy expenditure before and after Roux-en-Y gastric bypass.

Authors:  Silvia Leite Faria; Orlando Pereira Faria; Cynthia Buffington; Mariane de Almeida Cardeal; Heloisa Rodrigues de Gouvêa
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

Review 2.  Diet and body composition. Effect of very low calorie diets and exercise.

Authors:  J E Donnelly; J Jakicic; S Gunderson
Journal:  Sports Med       Date:  1991-10       Impact factor: 11.136

3.  Metabolic and neuroendocrine responses to Roux-en-Y gastric bypass. I: energy balance, metabolic changes, and fat loss.

Authors:  X Liu; A Lagoy; I Discenza; G Papineau; E Lewis; G Braden; J Romanelli; B Braun; J E Silva
Journal:  J Clin Endocrinol Metab       Date:  2012-05-14       Impact factor: 5.958

4.  Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

Authors:  M García-Caballero; M Valle; J M Martínez-Moreno; F Miralles; J A Toval; J M Mata; D Osorio; A Mínguez
Journal:  Nutr Hosp       Date:  2012 Mar-Apr       Impact factor: 1.057

5.  Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial.

Authors:  Torsten Olbers; Sofia Björkman; Ak Lindroos; Almantas Maleckas; Lars Lönn; Lars Sjöström; Hans Lönroth
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

6.  Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women.

Authors:  O L Svendsen; C Hassager; C Christiansen
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

7.  Exercise-training enhances fat-free mass preservation during diet-induced weight loss: a meta-analytical finding.

Authors:  D L Ballor; E T Poehlman
Journal:  Int J Obes Relat Metab Disord       Date:  1994-01

8.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

9.  Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study.

Authors:  Silvia Savastano; Carolina Di Somma; Luigi Angrisani; Francesco Orio; Salvatore Longobardi; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

10.  The significance of sarcopenia in old age.

Authors:  C Dutta; E C Hadley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-11       Impact factor: 6.053

View more
  12 in total

1.  A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.

Authors:  Gurvinder S Jammu; Rajni Sharma
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

2.  Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes.

Authors:  J Gómez-Ambrosi; P Andrada; V Valentí; F Rotellar; C Silva; V Catalán; A Rodríguez; B Ramírez; R Moncada; J Escalada; J Salvador; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2017-06-06       Impact factor: 5.095

3.  One Anastomosis Gastric Bypass/Minigastric Bypass in Patients with BMI < 35 kg/m2 and Type 2 Diabetes Mellitus: Preliminary Report.

Authors:  Salvador Navarrete Aulestia; José Luis Leyba; Salvador Navarrete Llopis; Viviana Pulgar
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 4.  Bariatric and metabolic surgery: a shift in eligibility and success criteria.

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2015-06-09       Impact factor: 43.330

5.  One Anastomosis Gastric Bypass in Morbidly Obese Patients with BMI ≥ 50 kg/m2: a Systematic Review Comparing It with Roux-En-Y Gastric Bypass and Sleeve Gastrectomy.

Authors:  Chetan D Parmar; Catherine Bryant; Enrique Luque-de-Leon; Cesare Peraglie; Arun Prasad; Karl Rheinwalt; Mario Musella
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

6.  NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity.

Authors:  Fàtima Sabench; Laia Bertran; Margarita Vives; Marta París; Carmen Aguilar; Salomé Martínez; Jessica Binetti; Monica Real; Alja Alibalic; Cristóbal Richart; Daniel Del Castillo; Teresa Auguet
Journal:  Obes Surg       Date:  2022-07-06       Impact factor: 3.479

7.  Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome.

Authors:  Silvia Paredes; Marta Alves; Maria Lopes Pereira; Olinda Marques; Laura Ribeiro
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

8.  Loss of skeletal muscle mass and its predictors in type 2 diabetes patients under a multifaceted treatment approach.

Authors:  Norihiko Ohara; Isao Minami; Ryotaro Bouchi; Hajime Izumiyama; Koshi Hashimoto; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  Diabetol Int       Date:  2017-07-13

9.  Impact of biliopancreatic limb length on severe protein-calorie malnutrition requiring revisional surgery after one anastomosis (mini) gastric bypass.

Authors:  Kamal Kumar Mahawar; Chetan Parmar; William R J Carr; Neil Jennings; Norbert Schroeder; Peter K Small
Journal:  J Minim Access Surg       Date:  2018 Jan-Mar       Impact factor: 1.407

10.  Laparoscopic One-Anastomosis Gastric Bypass: Technique, Results, and Long-Term Follow-Up in 1200 Patients.

Authors:  Miguel A Carbajo; Enrique Luque-de-León; José M Jiménez; Javier Ortiz-de-Solórzano; Manuel Pérez-Miranda; María J Castro-Alija
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.